Hiroko Murata

Title: Hiroko Murata: Innovator in Antibody Formulations

Introduction

Hiroko Murata is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of antibody formulations. With a total of 3 patents to her name, her work focuses on innovative solutions for stabilizing antibodies and improving their efficacy.

Latest Patents

Hiroko Murata's latest patents include formulations that contain anti-IL-31RA antibodies. One of her notable inventions is a lyophilized formulation that includes an IL-31 antagonist as an active ingredient, along with arginine and/or a salt thereof, and sucrose and/or trehalose. Additionally, she has developed solution formulations that also incorporate these components. Her patents detail methods for stabilizing antibodies, suppressing aggregation, and reducing charge heterogeneity in antibody formulations, emphasizing the importance of specific ingredients like arginine and sucrose.

Career Highlights

Hiroko Murata is currently employed at Chugai Seiyaku Kabushiki Kaisha, where she continues to advance her research in antibody formulations. Her innovative work has positioned her as a key figure in her field, contributing to the development of effective therapeutic solutions.

Collaborations

Hiroko has collaborated with notable colleagues such as Daisuke Kameoka and Toru Yoshizawa. These partnerships have further enhanced her research and development efforts in the biopharmaceutical industry.

Conclusion

Hiroko Murata's contributions to antibody formulation technology demonstrate her commitment to innovation in the field. Her patents reflect a deep understanding of biochemistry and a dedication to improving therapeutic outcomes.